Lipidomics Market Owing to Increased Pharmaceutical and Biological Manufacturing Industries

According to Precision Business Insights (PBI) latest report the global lipidomics market was valued at USD 50.0 million in 2021, growing at a CAGR of 8.0% during 2022-28. The increased focus on the R&D activities of Lipidomics, rise in funds from the government organizations, and availability of professional researchers and well-established infrastructure are all driving the global lipidomics market growth. The market players in the Lipidomics market are anticipated to have lucrative growth opportunities in the future with the rising demand for Lipidomics in the global market. However, the lipidomics market's growth is hampered by strict regulatory constraints, a lack of modern instruments, a lack of technology acceptance, and a scarcity of professional researchers.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/lipidomics-market/

Blood sample Segment Dominates the Lipidomics Market:
Based on application, the blood sample segment is expected to account for the largest share of the lipidomics market by 2028. Biomarker discovery is a medical phrase that refers to the process of finding biomarkers. Biomarkers are routinely used blood tests in medicine. The pharmaceutical industry is interested in biomarker discoveries; blood tests or other biomarkers could be used as intermediate markers of disease in clinical trials and as potential medication targets. This surge is due to increased regulatory intervention as lipidomics procedures become more important.
North America Leads Lipidomics Market:
Because of the large number of biopharmaceutical companies focused on lipidomics R&D, the increase in funds from government organisations, and the availability of professional researchers and well-established infrastructure, North America is anticipated to account for a significant revenue share in the global services market. Because of its increasing economy and urbanisation, the Asia-Pacific region is likely to provide considerable prospects for the industry.
.
Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
The global lipidomics market further reveals that the key players increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gaining significant geographic presence across the region. For instance, In December 2021, Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced that it had completed the transaction to acquire Protein Metrics, Inc., a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition expands the Company's R&D value chain to widen the biopharmaceutical protein analysis arena, unblocking data analysis bottlenecks currently associated with large-scale protein studies. In March 2021, Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods, today announced it had signed a non-exclusive license agreement with Quest Diagnostics the world leader in diagnostic information services, for Zora's patented ceramide-analysis technology.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=19551

The lipidomics market is segmented based on type, lipid source, application, and geography.
Based on the Type, the market is segmented into the following:
• Blood Sample
• Tissue Sample
• Others

Based on the Lipid source, the market is segmented into the following:
• Human Source
• Animal Source
• Plant Source

Based on the Application, the market is segmented into the following:
• Drug Discovery
• Biomarker Discovery
• Personalized Medicine
• Diagnosis and Treatment
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=19551

Key player's profiles in the lipidomics market report are Zora Biosciences OY, Owl Metabolomics, Avanti Lipids Polar, Inc, The Metabolomics Innovation Centre, Lipotype GmbH, Metabolon, Inc, Waters Corporation, Creative Proteomics, Thermo Fisher Scientific and MetaSysX.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.